Main programme

>> Sunday >> Monday >> Tuesday >> Wednesday




Wednesday 04 July 2018

08:30 - 09:45
Industry sponsored symposium

08:30 - 09:30
Session 58: Cochrane session: Industry and evidence in reproductive medicine: Managing the conflicts
Chairmen
Cindy M. Farquhar, New Zealand
Ernesto Bosch, Spain
08:30 - 09:00
Conflict of interest and bias: not your problem or is it?
Lisa Bero, Australia
09:00 - 09:30
We need some sunshine - making gifts from industry transparent
Paolo Vercellini, Italy

08:30 - 09:30
Session 59: Non-genetic factors influencing embryo viability
Chairmen
Borut Kovacic, Slovenia
Carmen Rubio LLuesa, Spain
08:30 - 09:00
Extrinsic factors disrupting embryo homeostasis
Speaker to be announced
09:00 - 09:30
Influence of maternal diet on preimplantation embryo development and long-term potential
Tom Fleming, United Kingdom

08:30 - 09:30
Session 60: Nurses/Midwives invited session: Towards parenthood
Chairmen
Hetty Ockhuysen, The Netherlands
Mercè Durban Llenas, Spain
Veronica Garrigos, Spain
08:30 - 09:00
Antenatal care in transition from fertility treatment to parenthood
Catja Warmelink, The Netherlands
09:00 - 09:30
Focussing on infertile men's needs
Randi Sylvest, Denmark

08:30 - 09:30
Session 61: ARTHIQS session: The evolving roles of competent authorities, professional organisations and the European Commission in ART
Chairmen
Georgi Nikolov, Bulgaria
Carlos Plancha, Portugal
08:30 - 08:42
Introduction: The roots and findings of ARTHIQS
William Nigel Strang, France
08:42 - 08:54
Competent authorities: From inspectorates to support structures
Anna Quinn, United Kingdom
09:06 - 09:18
The role of medical societies in promoting good practice and the scope for reprovigilance
Roy G Farquharson, United Kingdom
09:18 - 09:30
Closure: Future perspectives for competent authorities' cooperation
Carlos Plancha, Portugal

08:30 - 09:30
Product theatre

09:30 - 10:00
Coffee break

10:00 - 11:45
Session 62: From oocyte maturation in vivo to baby birth
Chairmen
Debbie Montjean, France
Karinna Lattes Altamirano, Spain
10:00 - 10:15
Immature oocyte incidence: Contributing factors and effects on intracytoplasmic sperm injection cycles
Daniela Braga, Brazil
10:15 - 10:30
The influence of denudation and injection on ICSI outcome - does timing matter?
Marta Carvalho, Portugal
10:30 - 10:45
The impact of intracytoplasmic sperm injection (ICSI) on embryo development as assessed by Time-Lapse (TL) microscopy on 4126 embryos
Irene Souter, U.S.A.
10:45 - 11:00
Differences in time-lapse practice: is a consensus on standards needed?
Cristina Hickman, United Kingdom
11:00 - 11:15
Deconstructing the myth of poor prognosis for fast-cleaving embryos on Day 3. Is it time to change the consensus?
Maria Carme Pons Gatell, Spain
11:15 - 11:30
Pregnancy and neonatal outcomes of embryos achieving blastulation on day 7: are they of clinical value?
Tong Du, China
11:30 - 11:45
The impact of extremely long term human embryo cryopreservation: embryonic, obstetric and neonatal outcomes
Yuan Yuan, China

10:00 - 11:45
Session 63: Male lifestyle and reproductive health
Chairmen
Lia Chkonia, Georgia
Jose Luis Ballesca, Spain
10:00 - 10:15
Has sperm quality been declining for the past 20 years?
Chuan Huang, China
10:15 - 10:30
Male reproductive health is a key determinant of unhealthy aging: results from a longitudinal cohort study.
Eugenio Ventimiglia, Italy
10:30 - 10:45
Spermatozoa from patients with seminal alterations and advanced age show lower reproductive competence in egg donation cycles
Valentina Casciani, Italy
10:45 - 11:00
Paternal lifestyle factors and its relationship to semen quality and in vitro reproductive outcomes
Daniela Braga, Brazil
11:00 - 11:15
The association between glycemic control and semen parameters
Avi Harlev, Israel
11:15 - 11:30
The effects of Mycoplasma genitalium infection on semen: A retrospective study in infertile men of our hospital in China
Gang Liu, China
11:30 - 11:45
Effect of nut consumption on semen quality and functionality in healthy males: a randomized controlled trial
Albert Salas-Huetos, Spain

10:00 - 11:45
Session 64: Novel insights for IVF protocols
Chairmen
Frank J. Broekmans, The Netherlands
Joaquim Calaf Alsina, Spain
10:00 - 10:15
Medroxyprogesterone acetate versus ganirelix in oocyte donation cycles stimulated using GnRH antagonist protocol triggered with GnRH-agonist: a randomized controlled trial (RCT)
Amelia Rodriguez Aranda, Spain
10:15 - 10:30
Triggering method dramatically alters the cumulus cell transcriptome in high and normal ovarian reserve patients
Brandon Wyse, Canada
10:30 - 10:45
Daytime variation in serum progesterone during the mid-luteal phase in women undergoing IVF treatment.
Lise Thomsen, Denmark
10:45 - 11:00
Effects of high progesterone in in-vitro fertilization cycle on DNA methylation of endometrium receptivity markers during implantation window
Yujing Xiong, Hong Kong
11:00 - 11:15
Implantation enhancement by elective Cryopreservation of all viable Embryos (ICE): randomized controlled trial (RCT) comparing the two safest approaches in IVF/ICSI for high-responders
Samuel Dos Santos-Ribeiro, Belgium
11:15 - 11:30
Oral dydrogesterone is an efficacious and safe alternative to intravaginal progesterone gel for luteal phase support in IVF: a randomized, open-label, multicenter, phase III study
Georg Griesinger, Germany
11:30 - 11:45
FSHR type is a risk factor for developing ovarian hyper stimulation syndrome during in vitro fertilisation as observed in vivo and in vitro
Hannah Nenonen, Sweden

10:00 - 11:45
Session 65: Improving IVF outcome
Chairmen
Edgardo Somigliana, Italy
Francisco Fabregues Gasol, Spain
10:00 - 10:15
Vaginal microbiota profile at the time of embryo transfer does not affect pregnancy in IVF cycles with donated oocytes
Paula Vergaro, Spain
10:15 - 10:30
Low ovarian response to stimulation in IVF can be related with activation of the NLRP3 inflammasome
Lisa Rancan, Spain
10:30 - 10:45
Do female age and body weight help to identify women who benefit from individualised gonadotropin dosing in IVF? A secondary analysis of the OPTIMIST study.
Jori Leijdekkers, The Netherlands
10:45 - 11:00
The vaginal microbiome as predictor for in vitro fertilization with or without intracytoplasmic sperm injection outcome; a prospective study
Rivka Koedooder, The Netherlands
11:00 - 11:15
Endometrial injury in women with previous in vitro fertilization and intra-cytoplasmic sperm injection failure: A systematic review and meta-analysis
Zhang Qiaoli, China
11:15 - 11:30
The use of non-donor egg IVF with embryo selection by morphology is efficient for patients aged 40-43
Fernando J. Prados-Mondéjar, Spain
11:30 - 11:45
Autologous stem cell ovarian transplant (ASCOT), allowed 5 pregnancies in poor responders (PR) women
Nuria Pellicer De Castellvi, Spain

10:00 - 11:45
Session 66: RIF and RM: new diagnostic approaches
Chairmen
Janine Elson, United Kingdom
Dolors Manau, Spain
10:00 - 10:15
Relationship between uterine natural killer (uNK) cells percentage and chronic endometritis in women with recurrent miscarriage
Yiwei Zhao, Hong Kong
10:15 - 10:30
Anti-Müllerian Hormone does not predict chance of live birth in 565 women with recurrent pregnancy loss
Sofie Bliddal, Denmark
10:30 - 10:45
The oestro-androgen dehydroepiandrosterone sulphate (DHEAS) may be a critical intracrine regulator of implantation and early pregnancy in Eumenorrhic non-PCOS women undergoing
Natachandra Chimote, India
10:45 - 11:00
Endometrial proteomic signature in recurrent implantation failure
Irem Demiral, Turkey
11:00 - 11:15
CRISPR/Cas9 genome editing to reveal the effect of implantation related genes on specific cell types which contribute to implantation process in human and mouse models
Gizem Nur Sahin, Turkey
11:15 - 11:30
T helper 1 cell level is associated with reproductive outcome of women with repeated implantation failures who received Tacrolimus treatment
Koji Nakagawa, Japan
11:30 - 11:45
Couples’ perspectives on their need for treatment, support and follow-up after recurrent pregnancy loss
Emily Koert, Denmark

10:00 - 11:45
Session 67: Current perspectives on preimplantation genetic testing and embryo selection
Chairmen
Ursula Eichenlaub-Ritter, Germany
Aïda Pujol, Spain
10:00 - 10:15
Improved embryo selection: a novel approach for simultaneous genomic and transcriptomic analysis from a single trophectoderm (TE) biopsy
Noga Fuchs Weizman, Canada
10:15 - 10:30
Pre-implantation genetic screening (PGS) of in vivo conceived and developed blastocysts recovered by lavage: Preliminary experience
Santiago Munne, U.S.A.
10:30 - 10:45
Comprehensive mitochondrial DNA (mtDNA) analysis and IVF outcome.
Belen Lledo, Spain
10:45 - 11:00
Improved concordance rates for aneuploidy detection in spent culture media compared to trophectoderm biopsies: a step forward towards non-invasive preimplantation genetic testing (niPGT-A)
Carmen Rubio LLuesa, Spain
11:00 - 11:15
Concordance rates among multiple trophectoderm samples and ICM remain high proving the efficacy of NGS for preimplantation genetic screening
John B. Whitney, U.S.A.
11:15 - 11:30
What is the genetic significance of blastomeres excluded from the formation of a morphologically normal blastocyst?
Caroline Pirkevi Cetinkaya, Turkey
11:30 - 11:45
Human in vitro post-implantation culture models reveal the depletion of aneuploid cells in chromosomally mosaic embryos 12 days post fertilisation
Mina Popovic, Belgium

11:00 - 12:00
Product theatre

12:00 - 13:15
Industry sponsored symposium

12:00 - 13:00
Session 68: Infertility around the globe
Chairmen
Dmitry Nikiforov, Italy
Diana Valbuena Perilla, Spain
12:00 - 12:30
Infertility and assisted reproduction in the muslim world: Social, cultural, and religious considerations
Marcia Inhorn, U.S.A.
12:30 - 13:00
The burden of infertility and childlessness in Sub-Saharan Africa: how can it be reduced?\r
Trudie Gerrits, The Netherlands

12:00 - 13:00
Session 69: Cumulative live birth rates after utilization of all fresh and frozen embryos in ivf/icsi - the optimal endpoint
Chairmen
Siladitya Bhattacharya, United Kingdom
Miguel Angel Checa Vizcaino, Spain
12:00 - 12:30
Number of oocytes and cumulative live birth rates following fresh and frozen embryo transfers
Sesh Kamal Sunkara, United Kingdom
12:30 - 13:00
Cumulative live birth rates after utilization of all fresh and frozen embryos in GnRH antagonist versus agonist protocol
Mette Toftager, Denmark

12:00 - 13:00
Session 70: Preconception genetics in clinical fertility practice: how much information do we need?
Chairmen
Cristina Magli, Italy
Mireia Sandalinas, Spain
12:00 - 12:30
Increasing use of mutation screening in fertility clinics
Dagan Wells, United Kingdom
12:30 - 13:00
Genetic carrier screening in gamete donor programs
Anna Veiga, Spain

12:00 - 13:00
Session 71: Laboratory invited session: Embryo culture: changing the atmosphere
Chairmen
Kersti Lundin, Sweden
Monica Parriego, Spain
12:00 - 12:30
Epigenetic changes by stimulation and culture
Arne Sunde, Norway
12:30 - 13:00
Impact of temperature on embryo culture
Ronny Janssens, Belgium

12:00 - 13:00
Product theatre

13:00 - 14:00
Lunch break

14:00 - 15:15
Session 72: New horizons in IVF
Chairmen
Ioannis Sfontouris, Greece
Elisabet Clua Obradó, Spain
14:00 - 14:15
Using artificial intelligence (AI) and time-lapse to improve human blastocyst morphology evaluation
Marcos Meseguer Escriva, Spain
14:15 - 14:30
Optimising Machine Learning Algorithms for the Non-Invasive analysis of the embryo secretome to enhance informed decisions imediately prior to embryo transfer
Steve Butler, United Kingdom
14:30 - 14:45
Automation in the IVF laboratory: preliminary results with a new device able to do both vitrification/rewarming of mice and bovine oocytes and embryos.
Pasquale Patrizio, U.S.A.
14:45 - 15:00
Single-cell RNA-seq reveals distinct dynamic behavior of sex chromosomes during human early embryogenesis
Qing Zhou, China
15:00 - 15:15
Parallel single-cell genome and transcriptome sequencing to study chromosomal instability during human embryonic preimplantation development
Elia Fernandez, Belgium

14:00 - 15:15
Session 73: ART-related complications
Chairmen
Kelly Tilleman, Belgium
Francisca Martinez, Spain
14:00 - 14:15
Oocyte retrieval complications: an update after 23,833 procedures in an academic tertiary care ART referral center.
Federico Cirillo, Italy
14:15 - 14:30
Transfer of two non-top quality embryos increases the risk of ectopic pregnancy after fresh and frozen-thawed embryo transfer
Simona Anzhel Ivanova, Finland
14:30 - 14:45
Hospitalizations due to OHSS after IVF is not diminished during the last 15 years despite presumed improvements in ovarian stimulation - National data from Denmark
Lotte Berdiin Colmorn, Denmark
14:45 - 15:00
Pregnancy after frozen-thawed embryo transfer during hormonal replacement cycle is associated with hypertensive disorders of pregnancy and placenta accreta.
Kazuki Saito, Japan
15:00 - 15:15
Pregnancy complications following assisted reproductive techniques - disentangling the role of multiple gestation
Sara Oberg, Sweden

14:00 - 15:15
Session 74: Factors affecting fertility potential PCOS women
Chairmen
Roy Homburg, United Kingdom
Julio Herrero Garcia, Spain
14:00 - 14:15
Endometrial expression of stanniocalcin-1 (STC-1) during the menstrual cycle in healthy women and in women with polycystic ovary syndrome (PCOS)
Terhi Piltonen, Finland
14:15 - 14:30
Clomiphene citrate or gonadotrophins in women with WHO type II anovulation and CC failure; a role for EMT?
Esmée Bordewijk, The Netherlands
14:30 - 14:45
The expression and regulation of inflammatory factor interleukin-18 in the proliferative phase endometrium of PCOS
Xiaoyu Long, China
14:45 - 15:00
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome - A Cochrane Systematic Review
Sebastian Franik, Germany
15:00 - 15:15
Higher probability of pregnancy after frozen-embryo transfer using a freeze-all policy compared to fresh-embryo transfer in high, but not in normal responder patients: a meta-analysis
Julia Bosdou, Greece

14:00 - 15:15
Session 75: What's new in the field of implantation and early pregnancy
Chairmen
Emma Kirk, United Kingdom
Rocio Nunez - Calonge, Spain
14:00 - 14:15
Endometrial receptivity assessment using a transcriptomic approach for personalized embryo transfer
Delphine Haouzi, France
14:15 - 14:30
Live birth rate after frozen-thawed embryo transfer according to endometrial preparation: mild gonadotropin ovarian stimulation leads to increased success compared to artificial cycle
Sylvie Epelboin, France
14:30 - 14:45
Early stop of progesterone supplementation after confirmation of pregnancy in IVF/ICSI fresh embryo transfer cycles of poor responders does not affect pregnancy outcome
Song-Po Pan, Taiwan R.O.C.
14:45 - 15:00
CSRP2BP is a novel marker in trophoblast development and preeclampsia pathogenesis
Yanlin Ma, China
15:00 - 15:15
Reproductive outcome following hyaluronic acid gel application after D&C in women with at least one previous curettage; long-term outcomes of a multicenter, prospective randomized trail.
Angelo Hooker, The Netherlands

14:00 - 15:15
Session 76: ART success and its factors
Chairmen
Georg Griesinger, Germany
Angela Palumbo, Spain
14:00 - 14:15
Transmission of oocyte DNA damage to preimplantation embryos after in vivo mouse exposure to daunorubicin and cytarabine.
Blandine Courbière, France
14:15 - 14:30
Dynamic regulation of germline-soma communication during oocyte meiotic maturation
Laleh Abbassi, Canada
14:30 - 14:45
Plasma microRNAs identified as novel markers of successful implantation.
Shirin Khanjani, United Kingdom
14:45 - 15:00
Progesterone/estradiol (P4/E2) ratio in hormone replacement cycles can predict ongoing pregnancy rates: a prospective study
Sagiri Taguchi, Japan
15:00 - 15:15
Progesterone levels but not endometrial thickness influence the effectiveness of freeze-only versus fresh embryo transfer: a prespecified subgroup analysis of a randomized clinical trial
Thi Ngoc Lan Vuong, Vietnam

14:00 - 15:15
Session 77: Female fertility from genomic studies to novel therapies
Chairmen
Andres Salumets, Estonia
Elena Labarta Demur, Spain
14:00 - 14:15
A comprehensive two-centre RNA-seq study reveals changes in endometrial and blood miRNome at mid-secretory phase in fertile women and in patients with recurrent implantation failure
Agne Velthut - Meikas, Estonia
14:15 - 14:30
Sirolimus as a new drug for treatment of RIF patients with elevated Th17/Treg Ratio: a randomized, double-blind, phase II clinical trial
Mohammad Nouri, Iran
14:30 - 14:45
No evidences that implantation of vitrified euploid blastocysts is influenced by ovarian stimulation conducted in luteal vs follicular phase:interim analysis of a prospective multicentre study
Alberto Vaiarelli, Italy
14:45 - 15:00
Age-related gene expression profiles of immature human oocytes
Myrthe Smits, The Netherlands
15:00 - 15:15
Age related differences in the translational landscape of mammalian oocytes
Edgar Del Llano, Czech Republic

15:30 - 16:30
Awards and closing ceremony
Basic Science for Oral Presentation Award
Award Winner
Basic Science for Poster Presentation Award
Award Winner
Clinical Science for Oral Presentation Award
Award Winner
Clinical Science for Poster Presentation Award
Award Winner
Fertility of Australia Exchange Award
Award Winner
Nurses Award
Award Winner
Welcome to Vienna
Thomas Ebner, Austria